Tag: Judy Garber

  • Nation & World

    Insight on triple-negative breast cancer

    Scientists from Harvard-affiliated Brigham and Women’s Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive “triple-negative” breast cancers and certain ovarian cancers are likely to respond to platinum-based chemotherapies.

    4 minutes
  • Nation & World

    Dilemmas of destiny

    As genetic testing and its offspring — personalized medicine — have matured, patients and doctors have become entangled in such issues as how to best share at-risk information, access treatment options, and weigh decisions about threats to the young and unborn. And sometimes these issues mushroom, becoming quandaries for society as a whole.

    9 minutes
  • Nation & World

    Genetic testing for breast or ovarian cancer risk may be greatly underutilized

    Although a test for gene mutations known to significantly increase the risk of hereditary breast or ovarian cancer has been available for more than a decade, a new study finds…

    3 minutes